Product Information
TOPIRAMATE 50 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0345 per EA under NDC 68462015305. Its NADAC has been published 291 times since Dec 2, 2020.
Strength
50 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462015305
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA077627On Market Since
3/27/2009
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 50 MG TABLET has been published 291 times since Dec 2, 2020, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0345 per EA |
|---|---|
| All-time high | $0.0546 (Jan 13, 2021) |
| All-time low | $0.0319 (Nov 20, 2024) |
| 52-week high | $0.0394 |
| 52-week low | $0.0345 |
| Median price | $0.0409 |
| Average price | $0.0420 |
| Largest weekly change | +31.7% (Aug 21, 2024) |
| Weeks tracked | 291 |
| Tracking since | Dec 2, 2020 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 50 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0345 per EA (NDC 68462015305), effective Jun 24, 2026.
How has the price of TOPIRAMATE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 50 MG TABLET has declined 34.6%. It has been tracked across 291 weekly CMS publications since Dec 2, 2020.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 50 MG TABLET?
Since Dec 2, 2020, the NADAC for TOPIRAMATE 50 MG TABLET has ranged from a low of $0.0319 (Nov 20, 2024) to a high of $0.0546 (Jan 13, 2021), with a median of $0.0409 per EA.
Are there cheaper alternatives to TOPIRAMATE 50 MG TABLET?
12 NADAC-published products share the same active ingredient, strength, and dosage form as TOPIRAMATE 50 MG TABLET, but none are currently priced below it.
Who manufactures TOPIRAMATE 50 MG TABLET?
TOPIRAMATE 50 MG TABLET (NDC 68462015305) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification